The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2−negative metastatic breast cancer: experience from the patient perspective
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2−negative metastatic breast cancer: experience from the patient perspective
Authors
Keywords
-
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 14, Issue 6, Pages 929-940
Publisher
Informa UK Limited
Online
2014-08-18
DOI
10.1586/14737167.2014.949243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009
- (2013) Rebecca H. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Toward Patient-Centered Drug Development in Oncology
- (2013) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- 1st International consensus guidelines for advanced breast cancer (ABC 1)
- (2012) F. Cardoso et al. BREAST
- Effect of HER2 status on distant recurrence in early stage breast cancer
- (2012) Kenneth R. Hess et al. BREAST CANCER RESEARCH AND TREATMENT
- The economic burden of metastatic breast cancer: a U.S. managed care perspective
- (2012) Alberto J. Montero et al. BREAST CANCER RESEARCH AND TREATMENT
- INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES
- (2012) Sonja V. Sorensen et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
- (2012) Laura Biganzoli et al. LANCET ONCOLOGY
- Evaluation of the Relationship Between Individual Well-Being and Future Health Care Utilization and Cost
- (2012) Patricia L. Harrison et al. Population Health Management
- Health-related quality of life among women with breast cancer – a population-based study
- (2011) Marie Høyer et al. ACTA ONCOLOGICA
- Clinical and biomarker predictors of side effects from tamoxifen
- (2011) Wendy Lorizio et al. BREAST CANCER RESEARCH AND TREATMENT
- Absenteeism and short-term disability associated with breast cancer
- (2011) Alex Z. Fu et al. BREAST CANCER RESEARCH AND TREATMENT
- Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer
- (2011) Helene Svensson et al. MEDICAL ONCOLOGY
- Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
- (2010) C K Lee et al. BRITISH JOURNAL OF CANCER
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
- (2010) O. Pagani et al. JNCI-Journal of the National Cancer Institute
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
- (2009) Fatima Cardoso et al. JNCI-Journal of the National Cancer Institute
- The Costs of Treating Breast Cancer in the US
- (2009) Jonathan D. Campbell et al. PHARMACOECONOMICS
- Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007
- (2008) Ali Montazeri JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Psychometric Validation of the Cancer Therapy Satisfaction Questionnaire
- (2008) Peter C. Trask et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now